Comparison of hepatitis B vaccine efficacy in Japanese students: a retrospective study

[1]  Jemal Yasin,et al.  Occupational exposure to blood and body fluids and associated factors among health care workers at the University of Gondar Hospital, Northwest Ethiopia , 2019, Environmental Health and Preventive Medicine.

[2]  I. Kamimaki,et al.  Virus Infection Control Based on the Second Edition of the Vaccine Guideline for Healthcare Professionals , 2018, Japanese Journal of Infection Prevention and Control.

[3]  O. Yokosuka,et al.  Key HLA‐DRB1‐DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine , 2018, Hepatology.

[4]  Noele P. Nelson,et al.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices , 2018, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[5]  H. Sahana,et al.  Decrease in Anti-HBs Antibodies over Time in Medical Students and Healthcare Workers after Hepatitis B Vaccination , 2017, BioMed research international.

[6]  F. Itoh,et al.  Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes , 2017, Journal of Gastroenterology.

[7]  Tokuaki Shobayashi,et al.  Introduction of a hepatitis B vaccine into the national routine immunisation programme of Japan. , 2016, The Lancet. Infectious diseases.

[8]  P. Revill,et al.  Overview of hepatitis B viral replication and genetic variability. , 2016, Journal of hepatology.

[9]  Y. Karino,et al.  Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan , 2016, Journal of gastroenterology and hepatology.

[10]  C. Sifri,et al.  Hepatitis B in healthcare workers: Transmission events and guidance for management. , 2015, World journal of hepatology.

[11]  T. Joh,et al.  Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection , 2015, PloS one.

[12]  S. Leonardi,et al.  Hepatitis B vaccine by intradermal route in non responder patients: An update , 2014 .

[13]  Ying Shi.  Correlation between hepatitis B virus genotypes and clinical outcomes. , 2012, Japanese journal of infectious diseases.

[14]  F. Itoh,et al.  Evaluation of usefulness of hepatitis B vaccination at St. Marianna University School of Medicine Hospital and related facilities , 2011 .

[15]  I. Cook.  Sexual dimorphism of humoral immunity with human vaccines. , 2008, Vaccine.

[16]  I. Cook.  Evidence based route of administration of vaccines , 2008, Human vaccines.

[17]  R. Ueda,et al.  Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection , 2006, Hepatology.

[18]  Yoshiyuki Suzuki,et al.  Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan , 2005, Journal of medical virology.

[19]  R. Jacobson,et al.  Prevention of Hepatitis B with the Hepatitis B Vaccine , 2004 .

[20]  M. Wahl,et al.  Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response. , 1987, Scandinavian journal of infectious diseases.